Tuesday, March 05, 2024 12:09:00 AM
See Attorney Clarke's Company's expertise: Scroll down to view my highlighted item: Regulatory Compliance, which is what the CE issue is all about.
Corporate and Securities
We have extensive experience advising companies and entrepreneurs from early-stage start-ups to mature publicly-traded companies. We represent clients in complex securities offerings, mergers & acquisitions and joint ventures, restructurings, as well as advise on related employment, intellectual property and tax matters. As a boutique law firm, we are unusually international and cross-border in scope, representing US and non-US clients across time zones.
Our experienced team provides key advice to start-ups and entrepreneurs, middle-market companies, high net-worth individuals and families, on a very broad range of corporate, securities and transactional matters. We speak a number of different languages and have experience working with cross-cultural teams, counterparties and clients. We represent clients in Europe, Asia and the Americas on inbound to the US and outbound transactions from the US, and other cross-border business activities.
Our client base and collective professional experience span a broad range of industries, including technology start-ups, biotechnology and life sciences companies, digital and mobile advertising, financial and investment services, fashion, food and beverage, mining, energy and natural resources, video gaming, manufacturing and publishing, consultancies, and medical device companies.
General Corporate Representation
We work with some of our clients as their outside general counsel. Our attorneys are responsive, service-oriented and experienced and have a core team of world-class professionals to provide crucial advice and support.
Structuring and entity formation.
Partnership, stockholder and LLC operating agreements.
Employment, consulting and equity compensation agreements.
Customer and vendor agreements.
Technology and other licensing agreements.
Website terms of use and privacy policies.
Regulatory compliance.
Corporate governance and company policies.
Corporate Transactions
We assist our clients in their execution of complex deals:
Private placements and public securities offerings.
Due diligence and advising on prospective investments.
Executive employment matters.
Mergers and acquisitions, stock and asset sales.
Strategic partnerships and joint ventures.
Business restructurings and spin-offs.
Termination and break-ups with principals and key employees.
Securities
We have significant experience representing clients in securities matters, including:
Initial and secondary public offerings.
Venture capital transactions, including seed financing and preferred rounds.
SEC reporting and disclosure requirements for US and non-US issuers.
Beneficial ownership reporting requirements.
Unregistered equity and debt offerings, including private placements and Rule 144A transactions.
Offerings outside of the US exempt under Regulation S.
PIPE deals.
Tender offers and going-private transactions.
Securities trading by directors and officers, including short swing profits issues and 10b5-1 plans.
Secondary market transactions, including resales of restricted and control securities.
Investment solicitation, finder and marketing activities.
Services
Corporate & Securities
Digital Media and Creative Ventures
Intellectual Property & Licensing
Tax
Hedge & Private Equity Funds
Start-up & Emerging Companies
Clean Technology Companies
Debt Finance and Restructuring
Litigation
Non-Profits and Foundations
Fashion & Consumer Goods
Data Privacy and Technology Law
Projects »
Practice Group
David W. Hsia
Wei-Li F. X. Tjong
Jennifer E.D. Clarke
Karin E. Weiner
Alison L. Bird
Z. Calhoun Kline
Judith A. Wise
Alice J. Lee
© 2011-2024 Tjong & Hsia LLP | 45 Rockefeller Plaza, 20th Floor, New
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM